纤维化:SIRT1仍然具有价值
Huailiang Wu1, Zhen Qiu1, Liyan Wang2
1Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Biomedicines
|September 28, 2024
概括
赛尔图因1 (SIRT1) 在纤维化中起着复杂的作用,影响衰老和炎症等过程. 了解SIRT1机制可能会揭示慢性病 (CKD) 治疗的新治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 慢性病 (CKD) 是一个重要的全球健康问题,纤维化是导致末期病的常见途径.
- 目前对纤维化的治疗方法有限,这凸显了对新型治疗策略的需求.
- Sirtuin 1 (SIRT1),一种依赖NAD+的脱乙酶,参与脏生理学和病理学,但其在纤维化中的确切作用仍在争论中.
研究的目的:
- 综合审查SIRT1在调节纤维化进展中的生物学作用和机制.
- 探索SIRT1作为缓解纤维化的治疗标的潜力.
- 为CKD的治疗方法和预后评估提供新的视角.
主要方法:
- 文献综述综合了关于SIRT1和纤维化的当前研究.
- 分析SIRT1在关键纤维化途径中的参与,包括脂质新陈代谢,上皮细胞-介质细胞过渡,氧化应激,衰老,炎症和自.
- 对SIRT1在纤维化模型中的保护性或有害作用的现有证据的评估.
主要成果:
- SIRT1影响纤维化所涉及的多个细胞过程,如氧化应激,炎症和自.
- 关于SIRT1的确切作用存在相互矛盾的发现,这表明情境依赖的效应.
- 有证据表明,SIRT1有潜力通过各种分子机制调节纤维化进展.
结论:
- SIRT1是纤维化复杂病变发生的关键调节者.
- 准SIRT1通路为开发用于CKD的新型治疗干预措施提供了一个有希望的途径.
- 需要进一步的研究来阐明精确的机制,并优化SIRT1治疗纤维化的策略.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
395
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
395
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K